Baxdela

Active Ingredient(s): Delafloxacin
FDA Approved: * June 19, 2017
Pharm Company: * MELINTA THERAPEUTICS INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Baxdela Overview

Delafloxacin (INN) (trade name Baxdela) is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.[1] It was developed and marketed by Melinta Therapeutics (formerly Rib-X Pharmaceuticals),[1] which subsequently merged with Cempra.[2] Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 References Medical use Delafloxacin is used to treat acute bacterial sk...

Read more Baxdela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Delafloxacin

Recent Baxdela Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Delafloxacin
  • Injection: 300mg
  • Powder: 300mg/vial
  • Tablet: 450mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Baxdela: (2 results)

Sorted by National Drug Code
  • 70842-101 Baxdela 450 mg Oral Tablet by Melinta Therapeutics, Inc
  • 70842-102 Baxdela 300 mg/10.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Melinta Therapeutics, Inc

Other drugs which contain Delafloxacin or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA